Natural Capsules Ltd. Share Price

Overview

Natural Capsules Ltd. share price is currently ₹142.04, down by - ₹5.29 (3.59%) from its previous closing price of ₹147.33. The share price has declined -15.06% over the past month and declined -35.91% over the past year. The stock's 52-week low and high are ₹134.87 and ₹231.14, respectively. Natural Capsules Ltd. has a market capitalisation of ₹ 170.00 Cr. The share price was last updated on 23 Oct 2026, 03:26 PM IST.

Natural Capsules Ltd.
Natural Capsules Ltd.
NATCAPSUQ
 ₹0.00
- ₹5.29
3.59%
Healthcare
 ₹0.00(%)1D

Updated: 23 Oct 2026, 03:26:59 pm IST

Market Data

Open Price

 ₹146.24

Prev. Close

 ₹147.33
 ₹142.04

Day Low

 ₹146.98

Day High

 ₹134.87

52 Week Low

 ₹231.14

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryMicro Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

-6.84

Sector PE

42.08

PB Ratio

0.67

Sector PB

5.48

EPS

-20.78

Dividend Yield

0.00

Today's Volume

9.909 K

5 Day Avg. Volume

4.498 K

PEG Ratio

0.00

Market Cap.

₹ 170.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About Natural Capsules Ltd. 👋

Natural Capsules Limited is an India-based hard capsule shell manufacturer, specialized in manufacturing an array of capsules, including hard gelatin capsules, vegetarian capsules, and various specialty variants. The Company offers a diverse range of capsule products to both domestic and international markets, serving the pharmaceutical and nutraceutical industries. Its offerings include hard gelatin capsules, hydroxypropyl methylcellulose (HPMC) vegetarian capsules and others, including shiny capsules, sweet capsules, fast-release capsules, regulatory variants, sodium laureth sulfate (SLS) free capsules, preservative free capsules and transmissible spongiform encephalopathy (TSE) free capsules. The Company, through its subsidiary, Natural Biogenex Private Limited, is focused on manufacturing APIs such as prednisolone, betamethasone, dexamethasone, and hydrocortisone along with their derivatives. It has two manufacturing facilities that are located in Bengaluru and Puducherry.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
SHUBINVESTS I SEBI RA

SHUBINVESTS I SEBI RA

5 Jun • 1:53 PM · SEBI-Registered Analyst

Hindustan Zinc Crashes 4% on Government Stake Sale Report

Hindustan Zinc shares fell 4.4% to ₹577 extending losses to 11% over six consecutive sessions after Bloomberg reported the government is considering selling up to 2% stake worth ₹5,000 crore. The sale could happen this month or in July with ICICI Securities, Axis Capital and HDFC Securities advising on the transaction. Upcoming supply hits market Investors anticipate large number of shares being sold at a discount existing holders sell now to avoid buying cheaper shares later stock falls before the sale even happens. THE GOVERNMENT'S DISINVESTMENT SPREE Coal India 2% stake sold ₹4,500 crore raised NHPC 6% stake sold ₹3,900 crore raised Hindustan Zinc November 2025 1.6% sold at ₹505 ₹3,500 crore raised Hindustan Zinc Now another 2% being considered ₹5,000 crore target Hindustan Zinc is fundamentally strong India's largest zinc and lead producer with consistent dividend payouts. The 11% fall in six sessions is entirely driven by supply fear not business deterioration. Once the stake sale is completed and overhang clears the stock typically recovers. Track official announcement of the stake sale timeline and floor price. If priced at a reasonable discount historically these OFS transactions have been good entry points for long term investors just like Coal India's OFS earlier.

HINDZINC
Hindustan Zinc's 11% crash on government stake sale reports taught me that disinvestment announcements create predictable supply overhang pressure on PSU stocks, and that understanding the government's disinvestment calendar is essential for investors in companies like Hindustan Zinc,
COALINDIA
Coal India and
NHPC
NHPC because each stake sale creates both a short term price risk and a potential long term buying opportunity once the overhang clears.

See More
THREETREND RESEARCH

THREETREND RESEARCH

9 Oct • 4:57 AM · SEBI-Registered Analyst

ncrease in Promoter Holding!📊🎯 1 Kalyani Forge 2 Quint Digital 3 G G Automotive 4 Mach Conferences 5 KCK Industries 6 Vijay Solvex 7 Natural Capsules 8 Lotus Eye Hospit 9 Positron Energy 10 Oxygenta Pharma 11 Sakthi Sugars 12 Kore Digital 13 Supreme Infra. 14 ***** 15 Gennex Lab.

KALYANIFRG

See More

Frequently Asked Questions

What is the share price of Natural Capsules Ltd.?

What is the market cap of Natural Capsules Ltd.?

Should I buy Natural Capsules Ltd. stock now?

What is the 52 week high and low of Natural Capsules Ltd.?

Is the Natural Capsules Ltd. stock good to buy?

Is Natural Capsules Ltd. a good buy for the long term?

Is Natural Capsules Ltd. overvalued or undervalued?

What is the PE and PB ratio of Natural Capsules Ltd.?

Start Now